Fenestra Launch

wmic-2

Fenestra Launch

MediLumine’s Fenestra® imaging agents for preclinical computed tomography will be presented at the upcoming WMIC.

Fenestra® LC and Fenestra® VC imaging agents are used for a wide array of applications in preclinical computed tomography and molecular imaging. These hepatocyte selective nanoemulsions help to enable co-registration of soft tissue CT data for multimodal molecular imaging, quantification of metastatic tumor burdens, 4D imaging for characterization of murine cardiovascular disease and quantitative assessments of anti-angiogenic therapies.

Come see us (booth #319) at the upcoming WMIC!

Share This Post

More To Explore

Come Visit Us at WMIC 2022 in Miami

We are looking forward to this year’s WMIC conference in Miami! Come meet Stephen Marchant (CEO MediLumine Inc.) and Felix Gremse (CEO Gremse-IT) at Booth

New Fenestra HDVC Publication

Fenestra HDVC is a non-toxic contrast agent for small animal in vivo microCT imaging.  Micro-computed tomography (micro-CT) imaging has been used to analyze organs in

Managed by Carbon Digital